NewsCBDWorrying CBD Hurdle For Professional Athletes

Worrying CBD Hurdle For Professional Athletes


EUROPEAN sportsman and women using CBD to boost performance have been warned they could fail dope tests.

The European Specialist Sports Nutrition Alliance (ESSNA) says that the risk of traces from THC entering athletes’ bodies after using CBD products is ‘too high to be ignored’.

In Europe, cannabidiol, of CBD, is becoming more and more popular with professional and amateur participants in sports such as running, athletics, golf and rugby.

The nutraingredients website reports that the ESNNA as counting major European sports nutrition players like Volac, Myprotein and Holland & Barrett among its membership.

It quotes the ESSNA as saying: “It is difficult to extract CBD from the cannabis plant without any traces of other cannabinoids, such as THC, being found in the final product. 

“Moreover, there are risks of cross contamination in manufacturing facilities if CBD products are produced in such environments.” 

Recent research in the UK on the validity of CBD products by the Centre for Medicinal Cannabis found widespread variance between labels and actual contents.

In almost 50% of cases, THC levels were above those advertised and therefore illegal, exposing sellers and users to potential legal action.

In 2018 The World Anti-Doping Agency (WADA) removed CBD as a banned substance and raised the legal THC limit from 15 nanograms/millilitre (ng/ml) to 150ng/ml.

In September, the United States Anti-Doping Agency slapped Colorado-based triathlete Lauren Goss with a six-month ban after THC levels in her blood exceeded the threshold. 

She blamed a CBD cream she was using out-of-competition for a ‘musculoskeletal injury.’

Many athletes say it can aid muscular recovery, pain relief. Therefore improving sleep and reducing inflammation.

Mark Tucker, CEO of UK-based CBD firm TTS Pharma, told nutraingredients that complete CBD-THC separation is possible under the right conditions.

TTS says it has developed ‘validated proprietary techniques for the extraction, separation and manufacturing of cannabinoids’.  

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

Tilray’s Medical Cannabis Product Now Available And Reimbursed Under Ireland’s Medical Cannabis Access Program

PRESS RELEASE TILRAY Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and...

Grow Group, Kanabo, MGC Pharma & Celadon Pharma All Report Growing Revenues, But Continue To Post Losses

AMID the economic chaos that dominated the headlines over the past week, nearly half-a-dozen UK-based or UK-listed cannabis companies...

MGC Pharma Announces Appointment Of UK Advisor And New COO/Deputy CEO

MGC Pharmaceuticals Ltd ('MGC Pharma' or 'the Company') a European based bio-pharma company specialising in the production and development...

Sanity Group’s Record Funding Round Led By BAT Could Bring More Big-Tobacco Capital To Cannabis, But Concerns Remain Over Conflicts Of Interest

LAST week Berlin-based cannabis operator Sanity Group closed Europe’s largest ever cannabis investment round worth €37.6m, bringing its total...

European Cannabis Stocks Review: £22m Wiped From LSE-Listed Cannabis Stocks Amid Market Chaos

FOLLOWING a few weeks of relative positivity for many of the stocks listed on the London Stock Exchange (LSE),...

German SPD Representatives Confident A Solution To International Legal Hurdles Will Be Found

EARLIER this month news broke that recent analysis conducted by the Bundestag's scientific service suggested the creation of a...

Must read

You might also likeRELATED
Recommended to you